Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000677597 | SCV001586725 | pathogenic | Mucopolysaccharidosis type 6 | 2023-03-14 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ARSB protein function. ClinVar contains an entry for this variant (Variation ID: 559814). This missense change has been observed in individual(s) with mucopolysaccharidosis type VI (PMID: 17458871, 22133300). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces tyrosine, which is neutral and polar, with serine, which is neutral and polar, at codon 266 of the ARSB protein (p.Tyr266Ser). |
Baylor Genetics | RCV000677597 | SCV004209247 | pathogenic | Mucopolysaccharidosis type 6 | 2023-08-01 | criteria provided, single submitter | clinical testing | |
Laboratory of Diagnosis and Therapy of Lysosomal Disorders, |
RCV000677597 | SCV000803114 | uncertain significance | Mucopolysaccharidosis type 6 | 2018-01-01 | flagged submission | curation | Absent from GnomAD (PM2) |